Regulatory & Compliance Support for Federal Pharmaceutical Sales

The contract provides ongoing support for regulatory and compliance activities related to federal pharmaceutical sales, ensuring adherence to key federal requirements such as small business status reporting, FAR Part 19 guidelines, FDA labeling standards, and DLA documentation protocols. The work is performed under a subcontract tied to the Defense Logistics Agency within the Department of Defense, with a NAICS code of 541611 indicating management consulting services, suggesting the support involves procedural guidance, documentation management, and regulatory interpretation rather than direct manufacturing or distribution. The contract was posted on August 5, 2026, and is linked to DLA award IDs SPE2DX25D9900 and SPE2DP26F8770, indicating its role in fulfilling broader defense supply chain obligations. Although specific performance location details are not provided, the scope implies nationwide or multi-site operations supporting federal procurement and pharmaceutical compliance systems.